Achieve Life Sciences focuses on developing therapies for nicotine addiction, showing promising results in clinical trials. Their innovative approach has garnered attention from investors, boosting stock prices. The company is well-positioned for growth, potentially transforming smoking cessation methods and contributing positively to public health.